BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 17969414)

  • 1. [An evaluation of damage caused by radiation and chemical drugs to urinary bladder mucosa in stage T1-T2N0V0 cancer].
    Kaprin AD; Pan'shin GA; Garmash SV; Kostin AA; Khmelevskiĭ EV; Elagin VO
    Vopr Onkol; 2007; 53(4):473-6. PubMed ID: 17969414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Assessment of mucosal injury in stage T1-T2NOMO bladder cancer after radiation or intravesical chemotherapy].
    Kaprin AD; Panyshin GA; Garmash SV; Kostin AA; Khmelevskiĭ EV; Elagin VO
    Vopr Onkol; 2008; 54(1):98-101. PubMed ID: 18416068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Preliminary results of selective combined therapy for patients with urinary bladder cancer].
    Zharinov GM; Agafonova MV; Tarazov PG; Suvorova IuV; Kozlov AA
    Vopr Onkol; 2003; 49(5):636-8. PubMed ID: 14682138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of the phase II EORTC 22971 trial evaluating combined accelerated external radiation and chemotherapy with 5FU and cisplatin in patients with muscle invasive transitional cell carcinoma of the bladder.
    Poortmans PM; Richaud P; Collette L; Ho Goey S; Pierart M; Van Der Hulst M; Bolla M;
    Acta Oncol; 2008; 47(5):937-40. PubMed ID: 18568488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Alternating radiochemotherapy in bladder carcinomas].
    Dunst J
    Strahlenther Onkol; 1998 Jun; 174(6):335-6. PubMed ID: 9645218
    [No Abstract]   [Full Text] [Related]  

  • 6. Platinum-based chemotherapy for bladder cancer.
    Waxman J; Wasan H
    Semin Oncol; 1994 Oct; 21(5 Suppl 12):54-60. PubMed ID: 7992067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraoperative radiation therapy for bladder cancer.
    Martinez A; Gunderson LL
    Urol Clin North Am; 1984 Nov; 11(4):693-8. PubMed ID: 6506374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Behavior of the urinary bladder mucosa following irradiation (therapy of radiation cystitis)].
    Albert L; Arndt J; Kriester A
    Radiobiol Radiother (Berl); 1969; 10(3):341-6. PubMed ID: 5349846
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prognosis for therapeutic effectiveness of radiotherapy in the combined treatment of cancer].
    Ivanov SD
    Vopr Onkol; 2008; 54(4):483-9. PubMed ID: 18942405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Some newer approaches to the treatment of the mucosa of patients with superficial bladder cancer: 1. Continuous bladder irrigation with 5-fluorouracil.
    Connolly JG; Anderson C; Johnson I
    Can Med Assoc J; 1979 Aug; 121(3):318-20. PubMed ID: 466604
    [No Abstract]   [Full Text] [Related]  

  • 11. Phase I-II RTOG study (99-06) of patients with muscle-invasive bladder cancer undergoing transurethral surgery, paclitaxel, cisplatin, and twice-daily radiotherapy followed by selective bladder preservation or radical cystectomy and adjuvant chemotherapy.
    Kaufman DS; Winter KA; Shipley WU; Heney NM; Wallace HJ; Toonkel LM; Zietman AL; Tanguay S; Sandler HM
    Urology; 2009 Apr; 73(4):833-7. PubMed ID: 19100600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [ Post-irradiation changes of the human bladder mucosa].
    De Dominicis R; Grechi G; Nori Bufalini G; Bongi G
    Arch De Vecchi Anat Patol; 1966 Oct; 48(1):77-112. PubMed ID: 5997464
    [No Abstract]   [Full Text] [Related]  

  • 13. Neoadjuvant and adjuvant chemotherapy in muscle-invasive bladder cancer.
    Calabrò F; Sternberg CN
    Eur Urol; 2009 Feb; 55(2):348-58. PubMed ID: 18977070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Frequency and stage of relapse after organ-saving combined treatment for urinary bladder cancer].
    Nabruzov SN; Vakhabov OU
    Vopr Onkol; 2008; 54(5):636-8. PubMed ID: 19069481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
    Kikuchi E; Fujimoto H; Mizutani Y; Okajima E; Koga H; Hinotsu S; Shinohara N; Oya M; Miki T;
    Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Combined treatment of bladder radiation injuries].
    Zadërin VP; Polianichko MF
    Vopr Onkol; 1982; 28(3):73-7. PubMed ID: 7064423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for local recurrence in patients with pTa/pT1 urinary bladder cancer.
    Jancke G; Damm O; Rosell J; Jahnson S
    Scand J Urol Nephrol; 2008; 42(5):417-21. PubMed ID: 18609266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility of early intravesical instillation chemotherapy after transurethral resection of the bladder: a prospective evaluation in a consecutive series of 210 cases.
    Engeler DS; Wyler S; Neyer M; Hobi C; Müller J; Schmid HP
    Scand J Urol Nephrol; 2008; 42(6):522-7. PubMed ID: 18609290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevention of urologic complications of radiotherapy of cancer of the female genital organs and bladder].
    Pronin VI; Kan IaD; Zverev MP
    Sov Med; 1987; (11):119-23. PubMed ID: 3127895
    [No Abstract]   [Full Text] [Related]  

  • 20. Chemotherapy for muscle-invasive bladder cancer treated with definitive radiotherapy: persisting uncertainties.
    Choueiri TK; Raghavan D
    Nat Clin Pract Oncol; 2008 Aug; 5(8):444-54. PubMed ID: 18577983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.